All Insights
UK and EU data protection post-Brexit: a brief guide
At 23:00 on 31 December 2020, the Brexit transition period came to end and a new UK data protection regime
How to instruct experts in patent cases correctly
The recent decision of Mr Justice Meade in Fisher & Paykel v Flexicare is yet another warning to patent practitioners
Cybersecurity Asia: People's Republic of China to treat data security as matter of national security
Beijing is evolving its cybersecurity approach, after unveiling draft laws that promise to elevate data protection into the domain of
What's in a name? Help your medicine go down well with consumers and regulators
The choice of the right brand name for a medicine or pharmaceutical product is essential for establishing a lasting market
Quantum computing | Ground-breaking commercial opportunities from solving the (as yet) unsolvable
Quantum computers will support powerful commercial applications by solving currently intractable problems. We consider the pathway to bringing this technology
Life sciences companies turn to public markets for injections of capital
London markets have remained open during the pandemic allowing for a surge in life sciences and healthcare sector deals including
Ethics and Compliance | New ethical controls coming for interactions with healthcare professionals in France
New rules coming into force on 1 October 2020 will give professional associations the power to block contracts or hospitality
A shot in the arm for generics as UK courts refuse injunction to prevent potential patent infringement
In an unusual decision for life sciences patent disputes, the UK courts refused to restrain a generic drug manufacturer from
